Arkolith/Insider Trading/IKNA/Form 4

Formela Jean Francois

DirectorIkena Oncology, Inc. (IKNA) · full profile →Form 4 · filed Apr 1, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
8
3 non-derivative · 5 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 30, 2021Conversion(C)750K——750K
Mar 30, 2021Conversion(C)2.9M——2.9M
Mar 30, 2021Conversion(C)1.1M——1.3M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 30, 2021Conversion(C)5.4M——0
Mar 30, 2021Conversion(C)7.9M——0
Mar 30, 2021Conversion(C)11.3M——0
Mar 30, 2021Conversion(C)9.5M——0
Dec 21, 2020Grant(A)5.4M$1.40$7.5M5.4M

Transaction Codes

C
Conversion of a derivative
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-21-014393) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML